OM Group to sell precious metals group for $750 M

• Publisher: Elsevier Science
• Year: 2003
• Weight: 33 KB
• Volume: 2003
• Category: Article
• ISSN: 1351-4180
• DOI: 10.1016/s1351-4180(03)00822-5

✦ Synopsis

development and production of pharmaceutical intermediates. AHF integrates the introduction of versatile aldehyde functionality with the formation of a chiral centre. Dow's new generation of chiral bisphosphite ligands is claimed to expand the scope of the technology beyond the vinylarene substrates.